Lantheus Holdings, Inc. (NASDAQ:LNTH) will release its Q416 earnings data on Tuesday, February 21st. Analysts expect Lantheus Holdings to post earnings of $0.13 per share and revenue of $70.78 million for the quarter. Persons interested in listening to the company’s earnings conference call can do so using this link.

Earnings History for Lantheus Holdings (NASDAQ:LNTH)

Lantheus Holdings, Inc. (NASDAQ:LNTH) opened at 9.05 on Friday. Lantheus Holdings, Inc. has a 52 week low of $1.82 and a 52 week high of $10.85. The firm’s 50 day moving average price is $8.86 and its 200-day moving average price is $8.50. The stock has a market cap of $323.30 million, a price-to-earnings ratio of 10.79 and a beta of 0.29.

Several equities research analysts have commented on LNTH shares. Credit Suisse Group restated a “hold” rating and issued a $9.00 price target on shares of Lantheus Holdings in a research note on Thursday, November 3rd. Jefferies Group LLC restated a “buy” rating and issued a $13.00 price target on shares of Lantheus Holdings in a research note on Thursday, November 3rd. Zacks Investment Research lowered shares of Lantheus Holdings from a “buy” rating to a “hold” rating in a research note on Saturday, October 29th. Royal Bank Of Canada raised their price objective on shares of Lantheus Holdings from $6.00 to $12.00 and gave the company an “outperform” rating in a research note on Tuesday, November 8th. Finally, RBC Capital Markets raised their price objective on shares of Lantheus Holdings from $6.00 to $12.00 and gave the company an “outperform” rating in a research note on Tuesday, November 8th. Three investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus target price of $9.96.

In related news, Director David F. Burgstahler sold 2,500,000 shares of the firm’s stock in a transaction that occurred on Monday, November 21st. The shares were sold at an average price of $9.00, for a total transaction of $22,500,000.00. The transaction was disclosed in a document filed with the SEC, which is available at this link. 1.33% of the stock is owned by company insiders.

“Lantheus Holdings, Inc. (LNTH) Scheduled to Post Earnings on Tuesday” was first published by Daily Political and is the sole property of of Daily Political. If you are accessing this article on another website, it was copied illegally and reposted in violation of U.S. and international copyright & trademark laws. The legal version of this article can be accessed at http://www.dailypolitical.com/2017/02/16/lantheus-holdings-inc-lnth-scheduled-to-post-earnings-on-tuesday.html.

About Lantheus Holdings

Lantheus Holdings, Inc develops, manufactures and commercializes diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. The Company’s portfolio of approximately 10 commercial products is spread across a range of imaging modalities.

5 Day Chart for NASDAQ:LNTH

Receive News & Ratings for Lantheus Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lantheus Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.